Reproxalap
N/A
Report date: 2026/03/09 20:02:04
NMEFirst In Class
Base Information
Drug NameReproxalap
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesAldeyra Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesAldeyra Therapeutics IncAbbvie Inc
Inactive CompaniesN/A
Active Indications
Inactive Indications